EAM
HZNP
Eagle Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-473,672
| Closed | -$48.7M | – | 570 |
|
|
2023
Q2 | $48.7M | Buy |
+473,672
| New | +$48.7M | 0.27% | 125 |
|
|
2023
Q1 | – | Sell |
-823,124
| Closed | -$93.4M | – | 586 |
|
|
2022
Q4 | $93.4M | Sell |
823,124
-99,882
| -11% | -$11.3M | 0.57% | 59 |
|
|
2022
Q3 | $57.1M | Sell |
923,006
-408,831
| -31% | -$25.3M | 0.37% | 97 |
|
|
2022
Q2 | $106M | Buy |
1,331,837
+19,643
| +1% | +$1.57M | 0.67% | 40 |
|
|
2022
Q1 | $138M | Sell |
1,312,194
-109,121
| -8% | -$11.5M | 0.71% | 38 |
|
|
2021
Q4 | $154M | Sell |
1,421,315
-95,381
| -6% | -$10.3M | 0.67% | 43 |
|
|
2021
Q3 | $166M | Sell |
1,516,696
-325,987
| -18% | -$35.7M | 0.75% | 24 |
|
|
2021
Q2 | $173M | Sell |
1,842,683
-584,637
| -24% | -$54.7M | 0.74% | 24 |
|
|
2021
Q1 | $220M | Buy |
2,427,320
+187,241
| +8% | +$16.9M | 0.97% | 8 |
|
|
2020
Q4 | $169M | Sell |
2,240,079
-686,792
| -23% | -$51.8M | 0.95% | 11 |
|
|
2020
Q3 | $229M | Buy |
2,926,871
+752,602
| +35% | +$58.8M | 1.18% | 2 |
|
|
2020
Q2 | $120M | Buy |
2,174,269
+303,708
| +16% | +$16.8M | 0.68% | 31 |
|
|
2020
Q1 | $55.4M | Sell |
1,870,561
-16,755
| -0.9% | -$496K | 0.34% | 109 |
|
|
2019
Q4 | $68.3M | Sell |
1,887,316
-617,886
| -25% | -$22.4M | 0.33% | 115 |
|
|
2019
Q3 | $68.2M | Sell |
2,505,202
-186,898
| -7% | -$5.09M | 0.35% | 106 |
|
|
2019
Q2 | $64.8M | Sell |
2,692,100
-5,377
| -0.2% | -$129K | 0.33% | 117 |
|
|
2019
Q1 | $71.3M | Sell |
2,697,477
-7,439
| -0.3% | -$197K | 0.38% | 103 |
|
|
2018
Q4 | $52.9M | Sell |
2,704,916
-64,525
| -2% | -$1.26M | 0.33% | 119 |
|
|
2018
Q3 | $54.2M | Buy |
2,769,441
+366,348
| +15% | +$7.17M | 0.26% | 160 |
|
|
2018
Q2 | $39.8M | Buy |
+2,403,093
| New | +$39.8M | 0.21% | 175 |
|
|
2016
Q4 | – | Sell |
-1,463,170
| Closed | -$26.5M | – | 680 |
|
|
2016
Q3 | $26.5M | Buy |
+1,463,170
| New | +$26.5M | 0.18% | 172 |
|